Kyle Bass Loses Challenge To Shire's Lialda Patent At PTAB
The Patent Trial and Appeal Board decided Wednesday that an organization started by hedge fund manager Kyle Bass failed to prove that Shire's patent on the bowel disease drug Lialda is...To view the full article, register now.
Already a subscriber? Click here to view full article